EmailHospital Circular 04/2002
Date Issued: 8 February 2002
Publication: 04/2002
Distribution: Public Hospitals
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals involved of a change to the Highly Specialised Drugs Program.
We have had recent advice from the Commonwealth that a new drug is to be added to the Highly Specialised Drugs Program, effective 1 March 2002.
1. ADD ITEM
Lopinavir with Ritonavir (Kaletra)
| 6340Q | Capsule 133.3mg-33.3mg | 90 | $322.50 | AB |
| 6341R | Oral liquid 400mg-100mg per 5mL, 60mL | 1 | $129.00 | AB |
Treatment in combination with two or more other anti-retroviral drugs of HIV infection in patients with CD4 cell counts of less than 500 per cubic millimetre, or viral load greater than 10,000 copies per mL.
EFFECTIVE: 1 March 2002
Any changes notified by hospital circular will be updated in the Guidelines on the internet and the relevant claim forms amended. Pharmacists are encouraged to check Victoria's Highly Specialised Drugs Program website to ensure they are using the correct claim forms or to request updated copies by fax on 03-9616 7764.
Mr Peter Donnelly
Director
Funding and Financial Policy
Metropolitan Health and Aged Care Services
